Study on predictive factors for chemotherapy-associated neutropenia in outpatients treated with paclitaxel
Project/Area Number |
22590138
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | University of Shizuoka |
Principal Investigator |
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | がん化学療法 / パクリタキセル / 好中球減少症 |
Research Abstract |
The aim of this study was to identify predictive risk factors for developing neutropenia after chemotherapy with paclitaxel. We successfully developed a new quantitative method for determination of blood paclitaxel concentration using LC-MS/MS. In clinical study, the wide interindividual variation in molar ratios of plasma 6α-hydroxypaclitaxel/ paclitaxel concentration was seen. More patients are, however, needed to identify predictive risk factors with paclitaxel-based chemotherapy.
|
Report
(4 results)
Research Products
(9 results)
-
[Journal Article] Influence of the Slow Infusion of a Soybean Oil Emulsion on Plasma Cytokines and Ex Vivo T Cell Proliferation After an Esophagectomy.2013
Author(s)
Yoshiyuki Kagawa, Toshio Maeda, Yasuhiro Kato, Iori Ueda, Tomoko Kudo, Naoe Watanabe, Midori Kimura, Sato Minami, Tatsuichiro Sakamoto, Hiroshi Yamada, Masakazu Takagi.
-
Journal Title
JPEN J Parenter Enteral Nutr
Volume: 37(1)
Issue: 1
Pages: 123-8
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-